|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50970696
???header.onlineuser??? :
891
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"narikazu"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-11 |
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 tri
|
Boku;Narikazu;Omori;Takeshi;Shitara;Kohei;Sakuramoto;Shinichi;Yamaguchi;Kensei;Kato;Ken;Kadowaki;Shigenori;Tsuji;Kunihiro;Ryu;Min-Hee;Oh;Do-Youn;Oh;Cheul, Sang;Rha;Young, Sun;Lee;Keun-Wook;Chung;Ik-Joo;Sym;Jin, Sun;Chen;Li-Tzong;Chen;Jen-Shi;Bai;Li-Yuan;Nakada;Takashi;Hagihara;Shunsuke;Makino;Reina;Nishiyama;Eiji;Kang;Yoon-Koo |
| 國立成功大學 |
2024-08 |
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, pl
|
Kang;Yoon-Koo;Terashima;Masanori;Kim;Young-Woo;Boku;Narikazu;Chung;Cheol, Hyun;Chen;Jen-Shi;Ji;Jiafu;Yeh;Ta-Sen;Chen;Li-Tzong;Ryu;Min-Hee;Kim;Gwang, Jong;Omori;Takeshi;Rha;Young, Sun;Kim;Yong, Tae;Ryu;Won, Keun;Sakuramoto;Shinichi;Nishida;Yasunori;Fukushima;Norimasa;Yamada;Takanobu;Bai;Li-Yuan;Hirashima;Yoshinori;Hagihara;Shunsuke;Nakada;Takashi;Sasako;Mitsuru |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
